AKUMS - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.2
| Stock Code | AKUMS | Market Cap | 7,079 Cr. | Current Price | 450 ₹ | High / Low | 623 ₹ |
| Stock P/E | 51.6 | Book Value | 151 ₹ | Dividend Yield | 0.00 % | ROCE | 16.2 % |
| ROE | 13.2 % | Face Value | 2.00 ₹ | DMA 50 | 440 ₹ | DMA 200 | 488 ₹ |
| Chg in FII Hold | -1.13 % | Chg in DII Hold | 5.13 % | PAT Qtr | 23.5 Cr. | PAT Prev Qtr | 44.9 Cr. |
| RSI | 59.9 | MACD | 1.39 | Volume | 95,628 | Avg Vol 1Wk | 1,12,777 |
| Low price | 405 ₹ | High price | 623 ₹ | PEG Ratio | 1.51 | Debt to equity | 0.02 |
| 52w Index | 20.7 % | Qtr Profit Var | -53.4 % | EPS | 8.71 ₹ | Industry PE | 29.1 |
📊 Analysis: AKUMS is trading at ₹450, slightly above its 50 DMA (₹440) but below its 200 DMA (₹488), reflecting mixed momentum. RSI at 59.9 indicates moderate strength, while MACD (1.39) shows a mild bullish signal. Intraday volume (95,628) is lower than the average weekly volume (1,12,777), suggesting limited participation. Fundamentals are decent with ROCE (16.2%) and ROE (13.2%), but recent quarterly PAT decline (-53.4%) and high P/E (51.6 vs industry 29.1) raise caution for intraday trades.
💡 Optimal Buy Price: ₹445–448 if price consolidates near support.
🎯 Profit-Taking Levels: ₹460–465 (short-term resistance zone).
🛡️ Stop-Loss: ₹438 to protect against downside risk.
⏱️ Exit Strategy (if already holding): Exit if price fails to sustain above ₹460 with strong volume. Momentum indicators suggest limited upside, so profit booking should be considered early to avoid reversal risk.
Positive
- ROCE (16.2%) and ROE (13.2%) show reasonable efficiency.
- DII holding increased by 5.13%, signaling strong domestic institutional support.
- Debt-to-equity ratio of 0.02 indicates virtually debt-free balance sheet.
- Trading above 50 DMA suggests short-term strength.
Limitation
- High P/E (51.6) compared to industry average (29.1).
- Quarterly PAT dropped sharply from ₹44.9 Cr. to ₹23.5 Cr. (-53.4%).
- Dividend yield at 0.00% reduces attractiveness for income investors.
- Intraday volume below average, limiting momentum trades.
Company Negative News
- No major negative news reported, but earnings decline raises concerns.
Company Positive News
- DII holding increased significantly (+5.13%), showing confidence from domestic institutions.
- EPS at ₹8.71 reflects steady profitability despite recent decline.
Industry
- Industry P/E at 29.1 indicates sector is moderately valued compared to AKUMS’ high valuation.
- Pharmaceutical sector benefiting from healthcare demand and expansion opportunities.
Conclusion
⚖️ AKUMS shows decent fundamentals but weak earnings momentum and stretched valuations. It is a moderate candidate for intraday trading with entry near ₹445–448 and profit-taking around ₹460–465. Traders should closely monitor volume and momentum indicators before committing to positions.